Bibliotecas PUC-SP - Busca Integrada

256 The TIGIT/CD226/CD155 axis and the effects of combining PD-1/PD-L1 blockade with TIGIT-targeting antibody therapy in syngeneic murine glioblastoma models

Por Ana Anderson, David Reardon, Bryan Iorgulescu, Gordon Freeman, Prafulla Gokhale, Max Klapholz, Michael Poitras, Benjamin Eschle
Publicado no Journal for ImmunoTherapy of Cancer (2021-11-01)

229 CX3CR1 in exhausted CD8 T cell states

Por Patrick Hwu, Apoorvi Chaudhri, Gregory Lizee, Yunfei Wang, Shao-Hsi Hung, Ulrich Von Andrian, Gordon Freeman
Publicado no Journal for ImmunoTherapy of Cancer (2021-11-01)

808 The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances responses to anti-PD-1 immunotherapy

Por Patrick Hwu, Apoorvi Chaudhri, Ping Hua, Xia Bu, Michael A Davies, Yunfei Wang, Shao-Hsi Hung, Ulrich Von Andrian, Gordon Freeman, Gregory A Lizee
Publicado no Journal for ImmunoTherapy of Cancer (2023-11-01)

442 CAIX targeted CAR-T cells exhibited antitumor efficacy on renal cell carcinoma (RCC) patient derived organotypic tumor spheroids (PDOTS)

Por Sabina Signoretti, Toni K Choueiri, Cloud Paweletz, Kun Huang, Yufei Wang, Gordon Freeman, Alicia Buck, Gabriella Kastrunes, Marion Grimaud, Atef Fayed, Luann Zerefa, Brandon Piel, Elena Ivanova, Miriam Ficial, Jon Wee, David Barbie, Wayne Marasco, Andras-Gabor Miklosi, Tran Thai, Ming-Ru Wu
Publicado no Journal for ImmunoTherapy of Cancer (2023-11-01)

700 Increasing MHC-I expression to potentiate immune checkpoint blockade therapy

Por Peng Jiang, Xia Bu, Michael Manos, Ana Lako, Scott Rodig, Yingtian Xie, Shengqing Gu, Henry Long, Paloma Cejas, Gordon Freeman, Wubing Zhang, Xiaoqing Wang, Nicole Traugh, Ziyi Li, Clifford Meyer, Blair Stewig, Alba Font-Tello, Klothilda Lim, Jake Conway, Alok Tewari, Zexian Zeng, Avinash Das Sahu, Collin Tokheim, Jason Weirather, Jingxin Fu, Benjamin Kroger, Jin Hua Liang, Benjamin Gewurz, F. Stephen Hodi, Myles Brown, X Shirley Liu
Publicado no Journal for ImmunoTherapy of Cancer (2021-11-01)